Glenview Trust co Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Glenview Trust co lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,349 shares of the medical equipment provider’s stock after acquiring an additional 2,607 shares during the period. Intuitive Surgical makes up approximately 1.1% of Glenview Trust co’s portfolio, making the stock its 24th largest position. Glenview Trust co’s holdings in Intuitive Surgical were worth $62,138,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the company. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at $27,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. 1248 Management LLC bought a new stake in Intuitive Surgical in the 1st quarter worth about $30,000. Finally, Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. HSBC increased their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Piper Sandler increased their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $607.17.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 7,562 shares of the business’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. The trade was a 95.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.4%

ISRG opened at $555.92 on Thursday. The firm’s 50 day simple moving average is $525.73 and its two-hundred day simple moving average is $505.69. The company has a market capitalization of $199.29 billion, a PE ratio of 73.53, a PEG ratio of 5.13 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.